Norman Schwartz - Sep 3, 2021 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Chairman, President, and CEO, Director, 10%+ Owner
Signature
/s/ Norman D. Schwartz
Stock symbol
BIO
Transactions as of
Sep 3, 2021
Transactions value $
-$3,057,481
Form type
4
Date filed
9/8/2021, 12:09 PM
Previous filing
Sep 3, 2021
Next filing
Sep 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +2.32K +0.55% $0.00 422K Sep 3, 2021 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$943K -1.15K -0.27% $819.70 421K Sep 3, 2021 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +2.6K +0.62% $0.00 424K Sep 4, 2021 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$1.06M -1.29K -0.3% $819.70 422K Sep 4, 2021 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +2.6K +0.62% $0.00 425K Sep 5, 2021 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$1.06M -1.29K -0.3% $819.70 424K Sep 5, 2021 Direct
holding BIO Bio-Rad B Common Stock 12.8K Sep 3, 2021 By Spouse F2
holding BIO Bio-Rad B Common Stock 4.06M Sep 3, 2021 By Blue Raven Partners, L.P. F3
holding BIO Bio-Rad B Common Stock 298K Sep 3, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Options Exercise $0 -2.32K -24.99% $0.00 6.96K Sep 3, 2021 Bio-Rad A Common Stock 2.32K $0.00 Direct F4, F5
transaction BIO Restricted Stock Units Options Exercise $0 -2.6K -33.33% $0.00 5.2K Sep 4, 2021 Bio-Rad A Common Stock 2.6K $0.00 Direct F4, F6
transaction BIO Restricted Stock Units Options Exercise $0 -2.6K -50% $0.00 2.6K Sep 5, 2021 Bio-Rad A Common Stock 2.6K $0.00 Direct F4, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 The reporting person disclaims beneficial ownership of these shares.
F3 The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F5 On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F6 On September 4, 2018, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F7 On September 5, 2017, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.